Versor Investments’s AtriCure ATRC Stock Holding History

Versor Investments’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,500	Closed	-$415K	–	83
2025 Q4	$415K	Sell	10,500 -4,635	-31%	-$170K	0.06%	383
2025 Q3	$534K	Buy	+15,135	New	+$521K	0.1%	295
2025 Q2	–	Sell	-7,200	Closed	-$232K	–	704
2025 Q1	$232K	Buy	7,200 +100	+1%	+$3.71K	0.04%	628
2024 Q4	$217K	Buy	+7,100	New	+$228K	0.04%	675
2023 Q2	–	Sell	-6,522	Closed	-$270K	–	623
2023 Q1	$270K	Buy	+6,522	New	+$271K	0.04%	533

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Versor Investments's ATRC Position: Q1 2026 in Review

Versor Investments sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 10,500 shares — an estimated $415K sold.

Versor Investments first reported a position in ATRC in Q1 2023 and held it in 5 quarters. The position peaked at $534K in Q3 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

Versor Investments reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
Versor Investments sold 10,500 AtriCure shares in Q1 2026, an estimated $415K.
Versor Investments first reported a position in AtriCure in Q1 2023 and held it in 5 quarters.
Versor Investments's AtriCure position peaked at $534K in Q3 2025.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.